Exploring the liver–kidney axis in the Ghanaian population: the RODAM prospective study
Journal of Global Health · 24.07.2026 · 16
DOI: 10.7189/jogh.16.04252 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Global Health, online erschienen am 24.07.2026. Verfasst von Muhulo Muhau Mungamba und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public and Occupational Health, Amsterdam University Medical Center, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Liver, Kidney. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, Intramural NIH HHS.
Abstract (Originalsprache)
Background
The liver-kidney axis has been increasingly recognised as a potential pathway linking metabolic dysfunction to chronic kidney disease (CKD). However, longitudinal evidence from sub-Saharan African populations remains limited. We therefore aimed to prospectively investigate the association of baseline liver biomarkers with incident CKD and its components over six years in a transcontinental cohort of Ghanaians living in rural and urban Ghana and Amsterdam, the Netherlands.
Methods
Using data from the prospective Research on Obesity and Diabetes among African Migrants cohort, we examined baseline liver biomarkers (gamma-glutamyl transferase (GGT), alanine aminotransferase (ALT), aspartate aminotransferase (AST) and the fatty liver index (FLI) in relation to incident CKD over approximately six years among Ghanaians in rural and urban Ghana and Amsterdam, The Netherlands. CKD was defined according to the Kidney Disease: Improving Global Outcomes 2021 criteria using race-free CKD-EPI equations. We used Poisson regression with robust standard errors to estimate adjusted incidence rate ratios (aIRRs) per standard deviation increases, adjusting for demographic, lifestyle, metabolic, and clinical factors. In fully adjusted models, we additionally accounted for longitudinal change (Δ) in liver biomarkers to isolate the association of baseline hepatic dysfunction with subsequent CKD risk.
Results
Among 1,832 participants free of CKD at baseline (mean age of 45.9 years, 63% female), the incidence of CKD was 11%, the incidence of albuminuria was 9.7%, and the incidence of decreased estimated glomerular filtration rate (eGFR) was 2.3% over the follow-up period. Incident CKD was independently associated with higher baseline GGT (aIRR = 1.12; 95% confidence interval (CI) = 1.01-1.23), ALT (aIRR = 1.27; 95% CI = 1.04-1.50), and AST (aIRR = 1.20; 95% CI = 1.04-1.34). Associations were primarily driven by albuminuria, while we observed no significant associations for decreased eGFR. In exploratory analyses, elevated FLI was associated with incident CKD (aIRR = 1.92; 95% CI = 1.14-3.18 and albuminuria (aIRR = 2.15; 95% CI = 1.24-3.68), suggesting a broader metabolic-hepatic phenotype linked to early renal injury. Effect estimates remained materially consistent after inverse probability weighting to address differential follow-up.
Conclusions
In our study, markers of liver cell injury were associated with increased risk of CKD over six years in the African population. Our findings support a potential link between hepatic metabolic dysfunction and early renal injury, highlighting the need for integrated cardiometabolic risk assessment in sub-Saharan Africa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Public and Occupational Health, Amsterdam University Medical Center, Amsterdam, The Netherlands.
- Department of Human Biology, Nelson Mandela Drive, Faculty of Health Sciences, Walter Sisulu University, Mthatha, South Africa.
- Department of Human Genetics and Epigenetics, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
- Department of Physiology and Anaesthesia/Critical Care, University of Ghana Medical School / Korle Bu Teaching Hospital, Accra, Ghana.
- Division of Endocrinology, Diabetes and Nutrition, University of Maryland School of Medicine, Baltimore, USA.
- Department of Molecular Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Förderung
- NIDDK NIH HHS
- Intramural NIH HHS
Zitieren
APA
Mungamba, M. M., Chilunga, F. P., van der Linden, E. L., Beune, E., Henneman, P., Hayfron-Benjamin, C. F., Catharina Meeks, K. A., Darko, S. N., Twumasi-Ankrah, S., Owusu-Dabo, E., Holleboom, A. G., Vogt, L., van den Born, B. J., Nkeh-Chungag, B. N., & Agyemang, C. (2026). Exploring the liver–kidney axis in the Ghanaian population: the RODAM prospective study. Journal of Global Health, 16. https://doi.org/10.7189/jogh.16.04252
Vancouver
Mungamba MM, Chilunga FP, van der Linden EL, Beune E, Henneman P, Hayfron-Benjamin CF, et al. Exploring the liver–kidney axis in the Ghanaian population: the RODAM prospective study. Journal of Global Health. 2026;16. doi:10.7189/jogh.16.04252
BibTeX
@article{Mungamba2026,
author = {Mungamba, Muhulo Muhau and Chilunga, Felix Patience and van der Linden, Eva L and Beune, Erik and Henneman, Peter and Hayfron-Benjamin, Charles Frederick and Catharina Meeks, Karlijn Anna and Darko, Samuel Nkansah and Twumasi-Ankrah, Sampson and Owusu-Dabo, Ellis and Holleboom, Adriaan Georgius and Vogt, Liffert and van den Born, Bert-Jan and Nkeh-Chungag, Benedicta Ngwenchi and Agyemang, Charles},
title = {Exploring the liver–kidney axis in the Ghanaian population: the RODAM prospective study},
journal = {Journal of Global Health},
year = {2026},
volume = {16},
doi = {10.7189/jogh.16.04252}
}
EUVIMED